Xofigo Ra-223 Radium Dichloride

Special Notice – Notice of Intent to Award a Sole Source Procurement

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Cardinal Health for the procurement of the following item:

0001: XOFIGO® (Radium-223 dichloride), Unit of Issue: EA, Qty.: 2,500

The proposed sole source procurement will be made with a price agreement set by Bayer Healthcare.

Bayer Healthcare provided a letter stating Cardinal Health is the sole source for XOFIGO® in the United States.

This notice is not to be considered a request for quotations or proposals. No contract will be awarded based on offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 7 days from the publication of this notice, a contract or order will be issued to Cardinal Health without any further notice.

The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements.